Current Medical Research and Opinion logo Informa Healthcare logo

Publisher: Informa Healthcare

Volume 22, Number 9, September 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Original Articles

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations
pp. 1623-1631(9)
Authors: Lefebvre, Patrick; Gosselin, Antoine; McKenzie, R. Scott; Mody, Samir H.; Piech, Catherine Tak; Duh, Mei Sheng

A polysomnography study of eszopiclone in elderly patients with insomnia
pp. 1633-1642(10)
Authors: McCall, W. Vaughn; Erman, Milton; Krystal, Andrew D.; Rosenberg, Russell; Scharf, Martin; Zammit, Gary K.; Wessel, Thomas

Review

Original Article

Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care
pp. 1661-1668(8)
Authors: Ruigómez, Ana; García Rodríguez, Luis Alberto; Wallander, Mari-Ann; Johansson, Saga; Dent, John

Letter to the Editor

Comment and reply on: The dose of aspirin for the prevention of cardiovascular and cerebrovascular events
pp. 1669-1670(2)
Authors: Serebruany, Victor; Fisher, Matt; Knappertz, Volker

Original Articles

A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis
pp. 1671-1678(8)
Authors: Kasper, Lloyd H.; Everitt, Daniel; Leist, Thomas P.; Ryan, Kathleen A.; Mascelli, Mary Ann; Johnson, Kenneth; Raychaudhuri, Aparna; Vollmer, Tim; The Multiple Sclerosis Investigators,

Development of a COPD severity score
pp. 1679-1687(9)
Authors: Wu, E.Q.; Birnbaum, H.G.; Cifaldi, M.; Kang, Y.; Mallet, D.; Colice, G.

Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%
pp. 1689-1697(9)
Authors: García-Feijoo, J.; Martínez-de-la-Casa, J.M.; Castillo, A.; Méndez, C.; Fernández-Vidal, A.; García-Sánchez, J.

Commentary

Single-dose famciclovir for the treatment of herpes labialis
pp. 1699-1702(4)
Authors: Hull, Christopher; Spruance, Spotswood; Tyring, Stephen; Hamed, Kamal

Original Articles

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study
pp. 1715-1723(9)
Authors: Goldstein, Barry J.; Weissman, Peter N.; Wooddell, Margaret J.; Waterhouse, Brian R.; Cobitz, Alexander R.

Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression
pp. 1737-1743(7)
Authors: Schmier, Jordana K.; Halpern, Michael T.; Covert, David W.; Robin, Alan L.

Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial
pp. 1745-1755(11)
Authors: Recker, Robert; Lips, Paul; Felsenberg, Dieter; Lippuner, Kurt; Benhamou, Laurent; Hawkins, Federico; Delmas, Pierre D.; Rosen, Clifford; Emkey, Ronald; Salzmann, Gretel; He, Weili; Santora, Arthur C.

Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study
pp. 1757-1764(8)
Authors: van den Boogaard, C.H.A.; Breekveldt-Postma, N.S.; Borggreve, S.E.; Goettsch, W.G.; Herings, R.M.C.

Review

Health-related quality of life burden of women with endometriosis: a literature review
pp. 1787-1797(11)
Authors: Gao, Xin; Yeh, Yu-Chen; Outley, Jackie; Simon, James; Botteman, Marc; Spalding, James

Original Articles

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension
pp. 1799-1805(7)
Authors: Suzuki, Emilio Rintaro; Meirelles Franklin, Luciana; da Silva, Luciano José Basilio; Figueiredo, Carlos R.L.; Agostini Netto, Joao; Batista, Wagner Duarte

Commentary

Original Articles

Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects
pp. 1813-1823(11)
Authors: Wemer, Johan; Cheng, Yi-Fang; Nilsson, Dag; Reinholdsson, Ingalill; Fransson, Bo; Lanbeck Vallén, Kerstin; Nyman, Lars; Eriksson, Catarina; Björck, Staffan; Schulman, Sam

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
pp. 1825-1837(13)
Authors: Machado, Márcio; Iskedjian, Michael; Ruiz, Inés; Einarson, Thomas R.

Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children
pp. 1839-1847(9)
Authors: Block, Stan L.; Schmier, Jordana K.; Notario, Gerard F.; Akinlade, Bolanle K.; Busman, Todd A.; MacKinnon, George E.; Halpern, Michael T.; Nilius, Angela M.

Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study
pp. 1849-1858(10)
Authors: Holzgreve, Heinrich; Risler, Teut; Trenkwalder, Peter

Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain
pp. 1859-1865(7)
Authors: Bhamb, Bhushan; Brown, David; Hariharan, Jaishree; Anderson, Jane; Balousek, Stacey; Fleming, Michael F.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A